Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distr...

FDA Drug Recall #D-0537-2026 - Class III, May 1, 2026

Recall Summary

Recall Number D-0537-2026
Classification Class III, Low risk
Date Initiated May 1, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Amerisource Health Services LLC
Location Columbus, OH
Product Type Drugs
Quantity 225,000 tablets

Product Description

Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-202-01; Individual Dose NDC: 68084-202-11

Reason for Recall

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Distribution Pattern

USA Nationwide

Lot / Code Information

Lot 1028739, exp 12/31/2027; Lot 1025622, exp 06/30/2027

Other Recalls from Amerisource Health Services LLC

Recall # Classification Product Date
D-0536-2026 Class III Primidone Tablets, USP, 250 mg, 100 Tablets (10... May 1, 2026
D-0418-2026 Class II Meclizine Hydrochloride Tablets, USP 12.5 mg, (... Mar 16, 2026
D-0338-2026 Class II Oxycodone Hydrochloride Tablets, USP (CII), 5 m... Jan 14, 2026
D-0101-2026 Class II Prazosin Hydrochloride, Capsules, USP, 1 mg, 10... Oct 16, 2025
D-0103-2026 Class II Prazosin Hydrochloride, Capsules, USP, 5 mg, 20... Oct 16, 2025

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections, all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.